Day: April 7, 2025

WARREN, N.J., April 07, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a healthcare company with dedicated efforts in immunotherapy and artificial intelligence, is unified by a commitment to advancing patient-centric solutions. The Company’s clinical-stage immunotherapy effort, Tevogen Bio, focuses on the development of off-the-shelf, genetically unmodified T cell therapeutics for infectious diseases and cancers. Its artificial intelligence effort, Tevogen.AI, aims to advance innovation in drug discovery, clinical trial efficiency, and patient access. Together, these efforts represent the foundational pillars of Tevogen’s broader vision to redefine the future of medicine. With this in mind, Tevogen today highlights the significant number of shares held by executive officers and members...

BURLINGTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2025 financial results on Thursday, May 1, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay through a webcast at www.lemaitre.com/investor. About LeMaitre LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures,...

HOUSTON, April 07, 2025 (GLOBE NEWSWIRE) — Occidental (NYSE: OXY) and its subsidiary 1PointFive today announced that the U.S Environmental Protection Agency approved its Class VI permits to sequester carbon dioxide (CO2) captured from STRATOS when the world’s largest Direct Air Capture (DAC) facility begins operating in Ector County, Texas. The permits, the first issued to sequester CO2 from a DAC project, allows Occidental to leverage its expertise managing large quantities of CO2 while advancing technology that strengthens the United States’ energy security and furthers economic growth in Texas. The permits, issued under the Safe Drinking Water Act’s Underground Injection Control program, are a critical component of Occidental’s plan to securely and durably store CO2 captured from the atmosphere. Throughout EPA’s rigorous...

At the close of business on 07 April 2025, Morten Opstad, chair of the board of IDEX Biometrics, held the following voting rights in IDEX, for the extraordinary general meeting on 11 April 2025. Total 142,779,329 shares or 17.17% of the share capital and votes, including shares held by Mr. Opstad and close relations. Some of the proxies may include voting instructions.Contact personsMarianne Bøe, Head of Investor Relations, Tel.: +47 918 00186Kristian Flaten, CFO, Tel.: +47 950 92322E-mail: ir@idexbiometrics.comAbout IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity.  Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and...

Company announcement No. 12/2025 7 April 2025 Treasury shares falling below 5% of share capital At the Annual General Meeting on 4 March 2025, a decision was passed to reduce the share capital by DKK 2,500,000 by cancelling 2,500,000 treasury shares. As a result of the cancellation of the 2,500,000 treasury shares, Netcompany’s ownership of treasury shares is now below 5% of the total share capital cf. the Danish Capital Markets Act, section 31. Additional informationFor additional information, please contact: Netcompany Group A/SThomas Johansen, CFO, + 45 51 19 32 24Frederikke Linde, Head of IR, +45 60 62 60 87Attachment12. Netcompany – Treasury shares falling below 5% of share capital

Company announcement No. 11/2025                                                 7 April 2025At the Annual General Meeting on 4 March 2025, a decision was passed to reduce the share capital by DKK 2,500,000 by cancelling 2,500,000 treasury shares. No objections to the share capital reduction have been received. Thus, registration of the share capital reduction was made by the Danish Business Authority on 7 April 2025. Following the cancellation of the 2,500,000 shares, the share capital of Netcompany Group A/S has a current nominal value of DKK 47,500,000 divided into 47,500,000 shares with a face value of DKK 1, corresponding to a total of 47,500,000 voting rights. Additional informationFor additional information, please contact: Netcompany Group A/SThomas Johansen, CFO, + 45 51 19 32 24Frederikke Linde, Head of IR, +45 60 62 60...

SANTIAGO, Chile, April 07, 2025 (GLOBE NEWSWIRE) — You are cordially invited to participate in Banco Santander Chile’s (NYSE: BSAC) conference call-webcast on Thursday, May 8, 2025, at 10.00 AM (EST time) where we will discuss 1Q 2025 financial results. The Bank’s Officers participating in the conference call are: Patricia Pérez, CFO, Cristian Vicuña, Chief Strategy Officer & Head of IR and Andrés Sansone, Chief Economist. A question and answer session will follow the presentation. The Management Commentary report will be published on April 30, 2025, before the market opens. The quiet period begins on April 15. To participate, the webcast presentation can be viewed at: https://mm.closir.com/slides?id=720987 Or please dial in using any of the below numbers:United Kingdom+44 203 984 9844USA +1 718 866 4614Austria...

OCALA, Fla., April 07, 2025 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (“AIM” or the “Company”) (OTC Pink: AIMI) — an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19 — announced that as of today its common stock is trading under the ticker AIMI on the Pink Open Market and the Special Meeting on April 30, 2025, about a reverse split is still on. For additional information, refer to AIM’s Definitive Proxy Statement filed April 2, 2025. About AIM ImmunoTech Inc.AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s lead product is a first-in-class investigational...

Binding decision outlines new three-year collective agreement with TCRC MONTREAL, April 07, 2025 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) announced today that it has received the arbitrator’s decision regarding the terms of its new collective agreement with the Teamsters Canada Rail Conference (TCRC). After six days of mediation and a comprehensive arbitration process, arbitrator William Kaplan delivered his ruling, establishing the terms of a new collective agreement between CN and the TCRC. The TCRC represents approximately 6,000 of our conductors, conductor trainees, yard coordinators and locomotive engineers across CN’s network in Canada. The new three-year agreement, effective from January 1, 2024, through December 31, 2026, includes an annual wage increase of 3%. This agreement replaces the previous one and does not require...